Difluvid 150mg Capsule

Fluconazole

DIFLUVID

INDICATIONS

For the treatment of systemic and mucosal candidiasis, eryptococcosis including meningitis. Prevention of fungal infections in predisposed patients as a result of cryptotoxic chemotherapy or radiotherapy and dermatomycosis.

DOSAGE AND ADMINISTRATION

Use in Adults

For prevention of relapse of oropharyngeal candidiasis in patients with AIDS, after the patient receives a full course of primary therapy, fluconazole may be administered at a 150 mg once weekly dose.

For the treatment of vaginal candidiasis, fluconazole 150 mg should be administered as a single oral dose. To reduce the incidence of recurrent vaginal candidiasis, a 150 mg once monthly may be used. The duration of therapy should be individualized, but ranges from 4-12 months. Some patients may require more frequent dosing. For candida balanitis, fluconazole 150 mg should be administered as a single oral dose.

The recommended dose for the prevention of candidiasis is 50 to 400 mg once daily, based on the patient's risk of fungal infection.

For dermal infections including tinea pedis, corporis, cruris and candida infections the recommended dosage is 150 mg once weekly. Duration of treatment is normally 2 to 4 weeks but tinea pedis may require treatment for up to 6 weeks. For tinea versicolor, the recommended dose is 300 mg once weekly for 2 weeks; a third weekly dose of 300 mg may be needed in some patients, whereas, in some patients, a single dose of 300 to 400 mg may be sufficient.

Note: The information given here is limited. For further information, kindly consult your doctor or pharmacist.

Caution: Foods, Drugs, Devices and Cosmetics Act prohibits dispensing without prescription.